Tag: Cancer: Lung
Women Have Lower Risk for Death After Resection for Lung Cancer
Restricted mean survival time difference was 0.84 years at 10 years for women undergoing pulmonary resection
ALA: Lung Cancer Survival Has Increased Nationally to 22.6 Percent
People of color face worse outcomes, have lower likelihood of being diagnosed early, receiving surgery
Less Than One in 20 Eligible Adults Receives Lung Cancer Screening
Lung cancer screening at the state level does not correlate with lung cancer burden
Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC
Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib
Use of Common Meds Tied to Lower Lung Cancer Mortality
Combined use of aspirin, statins, metformin tied to lower lung cancer risk and mortality
Atezolizumab Prolongs Survival in NSCLC With PD-L1 Expression
Overall survival longer than for chemotherapy in metastatic NSCLC with high PD-L1 expression
Lung Cancer Treatment Plans Changed Due to Pandemic
57 percent of patients receiving active treatment had at least one change in treatment plans
Respiratory, Lung Cancer Death Up Even With Low-Intensity Smoking
Risks for respiratory and lung cancer mortality increased for those smoking <10 cigarettes per day
Model Better Predicts Lung Cancer Risk for African Americans
Sensitivity for lung cancer screening greater with PLCOm2012 model than USPSTF criteria
AI Model Using Chest X-Ray May Predict 12-Year Lung Cancer Risk
CXR-LC model had better discrimination than CMS eligibility, similar performance to PLCO Model 2012
